Research Portfolio
We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
Filter for Grant pages
Keyword Search for Grant pages
Search Results
|
Title |
Institution |
Investigator |
Status |
Research Program Area |
| 00615A-T: Heritable and Sporadic Genetic Lesions in Canine Lymphoma | University of Minnesota | Jaime F Modiano, VMD PhD | Closed | Oncology - Lymphoma |
| 760: Cellular Genomics - Molecular Cytogenetic Investigation of Canine Soft Tissue Sarcomas | North Carolina State University | Matthew Breen, PhD | Closed | Oncology |
| 01029-A: Preliminary Pharmacokinetics and Palatability Study of Freeze-Dried Black Raspberries in Healthy Dogs | Ohio State University | Linda K. Lord, DVM, PhD | Closed | Oncology |
| 00910-A: Epidermal Growth Factor Receptor and Cyclooxygenase-2 Cross-Talk in Canine Mammary Cancers | Texas A&M University | Sakhila Banu, PhD | Closed | Oncology |
| 00990-A: Prognostic Indicators for Anal Sac Gland Carcinoma in the English Cocker Spaniel and Preparing to Map Predisposition to this Tumor | University of Cambridge | David Sargan, MA, PhD | Closed | Oncology |
| 00768: A Collaborative Study by Veterinary Oncologists, Pathologists and Diagnostic Laboratories to Enhance the Detection, Diagnosis and Treatment of Canine Lymphoma | University of Illinois | Ted Valli, DVM | Closed | Oncology - Lymphoma |
| 00978-A: Isolation of the Canine Telomerase Reverse Transcriptase (TERT) Subunit and Generation of Dominant-Negative Mutants for Telomerase Inhibition | University of Pennsylvania | Sam Long, PhD | Closed | Oncology |
| 00757A: Hereditary Mutations in Genes Associated with Osteosarcoma in Large Dog Breeds | Broad Institute | Kerstin Lindblad-Toh, PhD | Closed | Oncology - Osteosarcoma |
| 00757B: Hereditary Mutations in Genes Associated with Osteosarcoma in Large Dog Breeds | University of Michigan | Kenine Comstock, PhD | Closed | Oncology - Osteosarcoma |
| 00754B: Mapping of the Gene for Transitional Cell Carcinoma in the Scottish Terrier and West Highland White Terrier | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 778: Role of Regulatory T Cells in Dogs with Osteosarcoma | Colorado State University | Barbara J Biller, DVM | Closed | Oncology - Osteosarcoma |
| 00754A: Mapping of the Gene for Transitional Cell Carcinoma in the Scottish Terrier & West Highland White Terrier | Purdue University | Deborah Knapp, DVM | Closed | Oncology |
| 790: MicroRNA Profiling and MicroRNA-Based Treatment of Canine Cancers | Ohio State University | William C Kisseberth, DVM, PhD | Closed | Oncology |
| 00896-A: Phase I Clinical Trial and Pharmacokinetics of Intravesical Mytomycin C (MMC) for the Treatment of Canine Transitional Cell Carcinoma (TC) of the Urinary Bladder | Purdue University | Deborah Knapp, DVM | Closed | Oncology |
| 00888-A: Generation of Canine Single Chain Fragment Variable Antibody Libraries for the Identification and Targeting of Tumor-Associated Antigens in the Dog | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology |
| 00878-A: MicroRNA Expression in the Domestic Dog and Its Role in Canine Cancer | Texas A&M University | Kate L Tsai, PhD | Closed | Oncology |
| 822: Canine Comparative Oncology and Genomics Consortium (CCOGC) | Canine Comparative Oncology and Genomics Consortium Inc | Matthew Breen, PhD | Closed | Oncology |
| 00841-A: Pharmacokinetics and Phase I Clinical Trial of High-Dose Intermittent Oral Artemisinin in Dogs with Spontaneous Tumors | Ohio State University | Guillermo C. Couto, DVM | Closed | Oncology |
| 00848-A: Evaluation of Neutrophil Function in Treated Tumor-Bearing Dogs | University of Tennessee | Casey J. LeBlanc, DVM, PhD | Closed | Oncology |
| 00837-A: Prognostic Significance of Ezrin Expression in Canine High-Grade Soft Tissue Sarcoma | Colorado State University | Kathryn Vickery, VMD | Closed | Oncology |
| 00825-A: Microarray Analysis of Immune Responses Elicited by CERT + hGMCSF in Dogs With Advanced Cancer | Sirius Medicine, LLC | Kevin Morris, PhD | Closed | Oncology |
| 00826-A: Percutaneous Cryoablation in Canine Osteosarcoma | University of Wisconsin, Madison | Dale Bjorling, DVM | Closed | Oncology - Osteosarcoma |
| 00811-A: Gene Expression Profiling of Canine Lymphocytic Leukemia | Colorado State University | Anne Avery, DVM, PhD | Closed | Oncology |
| 595: The Development of a Cellular Delivery System for RNA Interference Targeted to Canine Tumors | University of Edinburgh | David J. Argyle, PhD | Closed | Oncology |
| 00809-A: Rel Transformation of Canine Lymphoid Cells: Towards the Development of Relevant Canine Lymphoma Cell Lines | North Carolina State University | Steven E. Suter, VMD, PhD | Closed | Oncology - Lymphoma |
| 00593A: Mapping Genes Associated with Canine Hemangiosarcoma | Broad Institute | Kerstin Lindblad-Toh, PhD | Closed | Oncology - Hemangiosarcoma |
| 678: Generation and Analysis of Canine Bone Marrow Derived Mast Cells | Ohio State University | Cheryl A. London, DVM, PhD | Closed | Oncology |
| 00593B: Mapping Genes Associated with Canine Hemangiosarcoma | Tufts University | Chieko Azuma, DVM, PhD | Closed | Oncology - Hemangiosarcoma |
| 591: In Vitro Effects of the Milk Thistle Extract Silibinin in Canine Tumor Cells | Colorado State University | Douglas H Thamm, VMD | Closed | Oncology |
| 00718-A: Ras Mutations in Canine Lymphoid and Myeloid Leukemias | University of Liverpool | Laura Blackwood, PhD | Closed | Oncology |
| 0002646T: Characterization of Receptor Tyrosine Kinase Dysfunction in Malignant Histiocytosis | Ohio State University | Cheryl A. London, DVM, PhD | Closed | Oncology |
| 00022101T: Development of Anti-Canine Il-2R? Antibodies Using CpG Oligodeoxynucleotide Vaccination | Oregon State University | Stuart Helfand, DVM | Closed | Oncology |
| 632: MicroRNAs and Canine Lymphoma | Ohio State University | William C Kisseberth, DVM, PhD | Closed | Oncology - Lymphoma |
| 349: Genetic Epidemiology of Cancer in the Golden Retriever | The Wistar Institute | K. Ann Jeglum, DVM | Closed | Oncology |
| 422: Tailored Antitumor Vaccines for Canine Hemangiosarcoma | University of Colorado Cancer Center | Don Bellgrau, PhD | Closed | Oncology - Hemangiosarcoma |
| 00664-A: Exploration of Alternative Samples for Prognostic Assay of Canine Cancers: Getting the Most Out of Existing Samples and Testing New Ones Collected Without Surgery | Animal Health Trust | Mike Starkey, PhD | Closed | Oncology |
| 00675-A: Evaluation of the Safety of Cisplatin/COX-2 Inhibitor Treatment for Canine Cancer | Purdue University | Deborah Knapp, DVM | Closed | Oncology |
| 00336A: Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 00336B: Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog | CNRS - University of Rennes | Francis Galibert, PhD | Closed | Oncology |
| 00257: Investigation of Predictors of Outcome for Canine Mast Cell Tumors | Auburn University | Elizabeth M. Whitley, DVM PhD | Closed | Oncology - Hemangiosarcoma |
| 366: Molecular Control of COX-2 Expression and Regulation of Prostaglandin Transport in Canine Mammary Tumors | University of Montreal | Monique Dore, DVM, PhD | Closed | Oncology |
| 00373A: Mapping Genes Associated with Osteosarcoma in Large Dog Breeds | Broad Institute | Kerstin Lindblad-Toh, PhD | Closed | Oncology - Osteosarcoma |
| 00373B: Mapping Genes Associated with Osteosarcoma in Large Dog Breeds | University of Michigan | Kenine Comstock, PhD | Closed | Oncology - Osteosarcoma |
| 00415: Anti-HLA-DR Antibody Therapy in Canine B-cell Lymphoma: Preliminary Clinical Evaluation | Cornell University | Rodney Page, DVM | Closed | Oncology - Lymphoma |
| 00339-A: Expression of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) in Canine Oral Malignant Melanoma | Auburn University | Kathryn Taylor, DVM | Closed | Oncology |
| 249: Genomics of Canine Brain Neoplasia | North Carolina State University | Matthew Breen, PhD | Closed | Oncology |
| 267: Investigation into Combined Molecular Approaches to Treat Hemangiosarcoma | University of Wisconsin, Madison | David J. Argyle, PhD | Closed | Oncology - Hemangiosarcoma |
| 272: Oligonucleotide Microarray Gene Expression Profiling of Canine Lymphoma | Ohio State University | William C Kisseberth, DVM, PhD | Closed | Oncology - Lymphoma |
| 237: Molecular Epidemiology of Ehrlichia and Bartonella spp. Infection in Golden Retrievers with Lymphoma | North Carolina State University | Edward B Breitschwerdt, DVM | Closed | Oncology - Lymphoma |
| 00205-A: Relationship of Clinical Stage and Ki-67 Expression to Recurrence Following Radiotherapy of Canine Intranasal Neoplasia | University of Wisconsin, Madison | WM Adams, DVM | Closed | Oncology |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
